Glioblastoma is a deadly cancer with intrinsic chemoresistance. Understanding this property will aid in therapy. Glucosylceramide synthase (GCS) is associated with resistance and poor outcome; little is known about glioblastomas. In glioblastoma cells, temozolomide and paclitaxel induce ceramide increase, which in turn promotes cytotoxicity. In drug-resistant cells, both drugs are unable to accumulate ceramide, increased expression and activity of GCS is present, and its inhibitors hinder resistance. Resistant cells exhibit cross-resistance, despite differing in marker expression, and cytotoxic mechanism. These findings suggest that GCS protects glioblastoma cells against autophagic and apoptotic death, and contributes to cell survival under chemotherapy.
Glucosylceramide Synthase protects Glioblastoma cells against autophagic and apoptotic death induced by temozolomide and paclitaxel / P. Giussani, R. Bassi, V. Anelli, L. Brioschi, F. De Zen, E. Riccitelli, M. Caroli, R. Campanella, S.M. Gaini, P. Viani, L. Riboni. - In: CANCER INVESTIGATION. - ISSN 0735-7907. - 30:1(2012), pp. 27-37.
Glucosylceramide Synthase protects Glioblastoma cells against autophagic and apoptotic death induced by temozolomide and paclitaxel
P. GiussaniPrimo
;R. BassiSecondo
;L. Brioschi;E. Riccitelli;S.M. Gaini;P. VianiPenultimo
;L. Riboni
2012
Abstract
Glioblastoma is a deadly cancer with intrinsic chemoresistance. Understanding this property will aid in therapy. Glucosylceramide synthase (GCS) is associated with resistance and poor outcome; little is known about glioblastomas. In glioblastoma cells, temozolomide and paclitaxel induce ceramide increase, which in turn promotes cytotoxicity. In drug-resistant cells, both drugs are unable to accumulate ceramide, increased expression and activity of GCS is present, and its inhibitors hinder resistance. Resistant cells exhibit cross-resistance, despite differing in marker expression, and cytotoxic mechanism. These findings suggest that GCS protects glioblastoma cells against autophagic and apoptotic death, and contributes to cell survival under chemotherapy.File | Dimensione | Formato | |
---|---|---|---|
PDF Giussani et al GCS in GBL 2012[1].pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
792.68 kB
Formato
Adobe PDF
|
792.68 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.